Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - Deferred ChargesCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

NovaBay Pharmaceuticals (NBY) Amortization - Deferred Charges (2023 - 2025)

NovaBay Pharmaceuticals (NBY) has disclosed Amortization - Deferred Charges for 2 consecutive years, with $33000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Amortization - Deferred Charges fell 93.87% to $33000.0 in Q4 2024 year-over-year; TTM through Sep 2025 was $33000.0, a 97.66% decrease, with the full-year FY2024 number at $904000.0, down 46.64% from a year prior.
  • Amortization - Deferred Charges was $33000.0 for Q4 2024 at NovaBay Pharmaceuticals, down from $138000.0 in the prior quarter.
  • In the past five years, Amortization - Deferred Charges ranged from a high of $655000.0 in Q3 2023 to a low of $33000.0 in Q4 2024.